Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks ...

Smart dosing for diabetes patients “is expected to dominate by the end of the decade, as CGM alone is just not sufficient for this patient population ... diabetes management off their plates,” he ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

“We believe that our patented technology—featuring a modular, eco-friendly design and cutting-edge sensor performance—represents a paradigm shift in the CGM market, which is projected to exceed $20 ...